Literature DB >> 24525293

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K study.

Masahiko Takai1, Masashi Ishikawa1, Hajime Maeda1, Akira Kanamori1, Akira Kubota1, Hikaru Amemiya1, Takashi Iizuka1, Kotaro Iemitsu1, Tomoyuki Iwasaki1, Goro Uehara1, Shinichi Umezawa1, Mitsuo Obana1, Hideaki Kaneshige1, Mizuki Kaneshiro1, Takehiro Kawata1, Nobuo Sasai1, Tatsuya Saito1, Tetsuo Takuma1, Hiroshi Takeda1, Keiji Tanaka1, Nobuaki Tsurui1, Shigeru Nakajima1, Kazuhiko Hoshino1, Shin Honda1, Hideo Machimura1, Kiyokazu Matoba1, Fuyuki Minagawa1, Nobuaki Minami1, Yukiko Miyairi1, Atsuko Mokubo1, Tetsuya Motomiya1, Manabu Waseda1, Masaaki Miyakawa1, Yoshikazu Naka1, Yasuo Terauchi2, Yasushi Tanaka3, Ikuro Matsuba4.   

Abstract

We retrospectively studied more than 1000 patients with type 2 diabetes attending 36 Japanese clinics to investigate the efficacy and safety of adding sitagliptin to various insulin regimens. We found that the treatment with add-on sitagliptin for 6-months was effective, irrespective of the type or dose of concomitant insulin.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Glycemic control; Insulin; Sitagliptin; Type 2 diabetes

Mesh：

Substances：

Year:  2014        PMID： 24525293     DOI： 10.1016/j.diabres.2013.12.045

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  7 in total

1.  Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study.

Authors:  Hiroshi Sakura; Naotake Hashimoto; Kazuo Sasamoto; Hiroshi Ohashi; Sumiko Hasumi; Noriko Ujihara; Tadasu Kasahara; Osamu Tomonaga; Hideo Nunome; Masashi Honda; Yasuhiko Iwamoto
Journal:  BMC Endocr Disord       Date:  2016-12-01       Impact factor: 2.763

2.  PERsistent Sitagliptin treatment & Outcomes (PERS&O 2.0) study, long-term results: a real-world observation on DPP4-inhibitor effectiveness.

Authors:  Antonio Carlo Bossi; Valentina De Mori; Carlotta Galeone; Davide Pietro Bertola; Margherita Gaiti; Annalisa Balini; Denise Berzi; Franco Forloni; Giancarla Meregalli; Federica Turati
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09

3.  Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes.

Authors:  Chunhong Shi; Ru Zhang; Ran Bai; Dan Liu; Yongbo Wang; Xueyang Zhang; Hao Wang; Jianling Du
Journal:  Clinics (Sao Paulo)       Date:  2019-04-29       Impact factor: 2.365

4.  Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study.

Authors:  Masahiko Takai; Masashi Ishikawa; Hajime Maeda; Akira Kanamori; Akira Kubota; Hikaru Amemiya; Takashi Iizuka; Kotaro Iemitsu; Tomoyuki Iwasaki; Goro Uehara; Shinichi Umezawa; Mitsuo Obana; Hideaki Kaneshige; Mizuki Kaneshiro; Takehiro Kawata; Nobuo Sasai; Tatsuya Saito; Tetsuo Takuma; Hiroshi Takeda; Keiji Tanaka; Shigeru Nakajima; Kazuhiko Hoshino; Shin Honda; Hideo Machimura; Kiyokazu Matoba; Fuyuki Minagawa; Nobuaki Minami; Yukiko Miyairi; Atsuko Mokubo; Tetsuya Motomiya; Manabu Waseda; Masaaki Miyakawa; Yasuo Terauchi; Yasushi Tanaka; Ikuro Matsuba
Journal:  J Clin Med Res       Date:  2019-04-14

5.  Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes.

Authors:  Shouhei Yuasa; Kazuyoshi Sato; Masahiko Takai; Masashi Ishikawa; Shinichi Umezawa; Akira Kubota; Hajime Maeda; Akira Kanamori; Masaaki Miyakawa; Yasushi Tanaka; Yasuo Terauchi; Ikuro Matsuba
Journal:  J Clin Med Res       Date:  2016-05-25

6.  Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus.

Authors:  Tomoyuki Katsuno; Hiroki Ikeda; Mitsuyoshi Namba
Journal:  Diabetes Ther       Date:  2016-04-25       Impact factor: 2.945

7.  A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes.

Authors:  Masahiko Takai; Masashi Ishikawa; Hajime Maeda; Akira Kubota; Kotaro Iemitsu; Shinichi Umezawa; Takehiro Kawata; Tetsuo Takuma; Hiroshi Takeda; Keiji Tanaka; Hideo Machimura; Fuyuki Minagawa; Atsuko Mokubo; Tetsuya Motomiya; Akira Kanamori; Ikuro Matsuba
Journal:  J Clin Med Res       Date:  2020-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.